Tag: Phase I Trial

Harmony Study

Alladapt Enrolling Participants for Clinical Study of OIT Therapy to Treat...

The study is still seeking participants 4-55 years of age.
Aquestive's Subingual Epinephrine

Aquestive Charts Ambitious Path Forward for Sublingual Emergency Epinephrine

Company updates the public on status of their candidate drug administered under the tongue.
AQST-108 Phase 1

Emergency Epinephrine Film Begins Phase 1 Clinical Trials

First healthy volunteer dosed in a Phase 1 study of AQST-108 for the treatment of allergic reactions including anaphylaxis.
Research

Aravax Presents Additional Positive Phase I Trial Results for PVX108, a...

Trial results demonstrate excellent PVX108 safety profile in patients with prior anaphylaxis and current asthma.
Researchers

Phase I Trial for New Peanut Allergy Immunotherapy Results in No...

Research details phase one study of peptide-based immunotherapy, which is designed to remove risks of acute reactions during treatment.
Poop Pills by OpenBiome

Can Fecal Transplant Cure Peanut Allergy? Phase I Trial Underway

Can transplanting the microbiota of a healthy person to that of an allergic individual prevent allergic reactions?
Nasal Spray

Phase I Trial of Epinephrine Nasal Spray for Anaphylaxis Begins

Could lead the way to approval of a less anxiety provoking method of epinephrine administration.
Researchers

Novel Peanut Allergy Vaccine Begins Phase I Clinical Trials

Vaccine uses peptides selected from parts of the peanut protein that do not cause life-threatening anaphylactic reactions.

Viaskin Milk Patch Receives Positive Recommendation to Proceed to Phase II

The board overseeing the Phase I study of the milk allergy therapy found no safety concerns.